Although mutations in the actin β (ACTB) gene are infrequent in cancer generally, their prevalence increases in highly invasive cancers, such as metastatic melanoma and diffuse large B-cell lymphoma (https://www.cbioportal.org/). Here, ACTB is linked to diffuse large B-cell lymphoma.